Therefore, KETO, when managed carefully, contributes to fat breakdown and enhanced insulin signaling, thus counteracting the onset and progression of steatotic liver disease [267] while concomitantly improving associated comorbidities like obesity and T2DM. This evidence concerns the gene INS and liver disorder.